Tablets Capsules

TC0321

Issue link: https://www.e-digitaleditions.com/i/1349974

Contents of this Issue

Navigation

Page 15 of 59

14 March/April 2021 Tablets & Capsules A Martin Koeberle and Verena Garsuch Hermes Pharma Ensuring stability in pharmaceutical and dietary supplement manufacturing stability This article discusses the costs and consequences of instability in pharmaceuticals and dietary supplements and describes sev- eral methods and practices manufacturers can use to ensure the stability of their raw materials and final products. chieving adequate and reliable stability of finished drug products is a long-standing and complex challenge for manu- facturers of pharmaceuticals and dietary supplements. Many active pharmaceutical ingredients (APIs) and other ingre- dients are inherently unstable, and exposure to moisture, oxygen, and other elements during processing and storage can further exacerbate instability. Unsuitable storage con- ditions or poor handling of intermediate materials during manufacturing can also have an impact. After manufacturing,

Articles in this issue

Archives of this issue

view archives of Tablets Capsules - TC0321